3M Health Care and Greystone Pharmaceuticals, Inc. Announce License Agreement for Innovative Wound Care Technology

Published: Jul 17, 2008

ST. PAUL, Minn.--(BUSINESS WIRE)--3M Health Care and Greystone Pharmaceuticals, Inc. today announce they have entered into an exclusive, worldwide license agreement for wound care products using Greystone’s patented PHI technology, a proprietary formulation that aids in the management of hard-to-heal wounds.

Back to news